circRNA is a potential target for cardiovascular diseases treatment

Mol Cell Biochem. 2022 Feb;477(2):417-430. doi: 10.1007/s11010-021-04286-z. Epub 2021 Nov 15.

Abstract

Circular RNAs (circRNAs), a novel class of endogenous noncoding RNA, are characterized by their covalently closed-loop structures without a 5' cap or a 3' poly(A) tail. With the evolution of high-throughput sequencing technology and bioinformatics, an increasing number of circRNAs have been discovered, and their functions were highlighted. Cardiovascular diseases (CVDs) have become the world's leading killers, with serious impacts on human health. Although significant progress has been made in clarifying the development of CVDs from the molecular to the cellular level, CVDs remain one of the leading causes of death in humans. circRNAs mainly function as a "sponge" to absorb microRNAs, which results in the positive control of downstream proteins. They play important regulatory roles in the development of CVDs. This paper reviews current knowledge on the biogenesis, detection and validation, translation, translocation and degradation, and general functions of circRNAs, with a focus on their roles in CVDs.

Keywords: Cardiovascular diseases; circRNA; m6A modification; microRNA.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases* / genetics
  • Cardiovascular Diseases* / metabolism
  • Cardiovascular Diseases* / therapy
  • Computational Biology
  • High-Throughput Nucleotide Sequencing
  • Humans
  • MicroRNAs / genetics
  • MicroRNAs / metabolism
  • RNA, Circular* / genetics
  • RNA, Circular* / metabolism

Substances

  • MicroRNAs
  • RNA, Circular